Rocky Mountain Cancer Centers - Denver - Midtown — Denver, Colorado

Rocky Mountain Cancer Centers - Denver - Midtown is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers - Denver - Midtown has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Gastro-enteropancreatic Neuroendocrine Tumor, Carcinoma, Non-Small-Cell Lung, Metastatic Non-small Cell Lung Cancer.

Sponsors: Camurus AB, Mirati Therapeutics Inc., Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers - Denver - Midtown?

Rocky Mountain Cancer Centers - Denver - Midtown has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers - Denver - Midtown conducted?

Rocky Mountain Cancer Centers - Denver - Midtown has 3 clinical trials on record, with 1 currently active. Their work covers Gastro-enteropancreatic Neuroendocrine Tumor, Carcinoma, Non-Small-Cell Lung, Metastatic Non-small Cell Lung Cancer.

Is Rocky Mountain Cancer Centers - Denver - Midtown accredited by Crixeo Health?

Rocky Mountain Cancer Centers - Denver - Midtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers - Denver - Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.